Do You Have Fibromyalgia?
Now Enrolling for a Local Investigational Study
SEARCHING FOR INDIVIDUALS WHO STRUGGLE WITH FIBROMYALGIA!
Sign Up to Apply Today!
A member of our staff will be in contact with you shortly.
Why Should I Participate?
Do you feel like you’re being bullied by your Fibromyalgia? We are searching for Springfield area applicants to participate in a clinical research study investigating a new medication to improve options for people diagnosed with Fibromyalgia. If you believe you’d be a good fit for this study, contact Clinvest Research for more information.
What Should I Expect?
The purpose of this research study is to assess the effectiveness and safety of an investigational study medication at multiple dosages compared to a placebo in adults with Fibromyalgia. Participation in this study is approximately 21 weeks including up to a 5 week screening period and 16 week double-blind treatment period. There will be approximately 7 visits. The study medication and all study-related procedures are provided to eligible participants at no cost (including basic study-related physical exams, ECG’s and lab tests). If you qualify to participate, reimbursement may be provided for your time.
To Find Out More
Learn More About Our Studies
Clinvest Research is a clinical investigation company based in southwest Missouri. We are constantly seeking participants for clinical trials in order to further options for sufferers of various conditions. Our doctors are a part of a select group of clinics in the U.S. that have been involved in over 200 Phase II-IV clinical research studies sponsored primarily by the pharmaceutical industry or studies created by doctors after patient observation.
Study visits are conducted via outpatient and do not require overnight stays. In fact, we pride ourselves in making your participation in the studies as easy and convenient as possible.
If you qualify and choose to join a study, you will be treated by our team of specialists and may receive study-related care at no cost. Call us at 417.883.7889 to learn more.